The Pharmacokinetics Of Tetracaine, Para-Butylaminobenzoic Acid, And Oxymetazoline After Intranasal Administration Of The Highest Phase 3 Dose Of Kovacaine Mist To Healthy Volunteers

Trial Profile

The Pharmacokinetics Of Tetracaine, Para-Butylaminobenzoic Acid, And Oxymetazoline After Intranasal Administration Of The Highest Phase 3 Dose Of Kovacaine Mist To Healthy Volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Dec 2016

At a glance

  • Drugs Oxymetazoline/tetracaine (Primary)
  • Indications Dental pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 19 Jul 2016 Results of population pharmacokinetics of two phase II studies including this study published in the Journal of Clinical Pharmacology
    • 31 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top